Mylan Pharmaceuticals Inc. has issued a voluntary nationwide recall for a single batch of the anti-anxiety medication Xanax (alprazolam).

The recall involves Alprazolam Tablets USP C-IV 0.5 mg, in 500-count bottles, Lot No. 8082708, with an expiration date of September 2020. The lot was distributed in the U.S. between July and August 2019.

The company cited a small chance of infection to patients in the recall notice, but did not elaborate on what the foreign contaminant may be.

“Clinical impact from the foreign material, if present, is expected to be rare, but the remote risk of infection to a patient cannot be ruled out,” Mylan said.

The company urges consumers to contact a healthcare professional if they have experienced any problems that might be due to this product.

Consumers with questions can contact Mylan Customer Relations at 800.796.9526 or, Monday through Friday from 8 a.m. – 5 p.m. EST.

Xanax Recalled Due to Foreign Substance and Infection Risk

Source: Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance

Posted by Daily Hornet

We aim to provide progressive news that covers politics and corporate wrongdoing. We have no corporate interests to serve. No hidden agenda. We’re here to bring you the news you need to know with a grassroots twist.